MALVERN, Pa., July 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that three presentations related to plantar fibromatosis (PFI) and plantar fasciitis (PFA) will be shared during ...

Plantar fibromatosis is a rare condition, and most newly diagnosed patients receive conservative (nonsurgical) treatments. Real-world treatment patterns suggest symptoms may persist or return, ...

Please provide your email address to receive an email when new articles are posted on . Use of collagenase clostridium histolyticum for plantar fibromatosis may improve nodular hardness and ...

Previously unpublished clinical data support the potential long‑term safety and efficacy of collagenase clostridium histolyticum (CCH) for plantar fibromatosis. The findings will be presented at the ...

Plantar fibromatosis, commonly referred to as Ledderhose disease, is a benign yet locally aggressive proliferation of fibroblasts and collagen within the plantar fascia. Clinically, it presents as ...

Last fall, I got to chatting with Peter McAllister, M.D., neurologist and Chief Medical Officer of the New England Institute for Clinical Research, when the talk turned to toxins-botulism toxin, to be ...

Plantar fibromatosis is a progressive condition with no FDA-approved nonsurgical treatment options. With no official treatment guidelines available, Keenova and its clinical partners are working to ...